Prostate cancer decisions — 2015

The Veteran's appeal for an initial compensable rating for prostate cancer status post-prostatectomy without residuals associated with herbicide exposure was denied. The Board found that the Veteran does not currently have prostate cancer or residuals of prostate cancer manifesting symptoms of renal dysfunction or voiding dysfunction.

The Board has determined that the Veteran's residuals of prostate cancer do not warrant a rating in excess of 40 percent from October 1, 2009.

The Board has remanded the case due to insufficient evidence and a need for further development, including obtaining VA treatment records, personnel records, and SSA records. The Veteran's prostate cancer may be related to his service in Korea, but more evidence is needed to determine this.

The Veteran's claim for service connection for prostate cancer, claimed as due to herbicide exposure, is being remanded for further development.

The Board has determined that the reduction in the disability rating for residuals of prostate cancer from 100% to 40% was proper, effective June 1, 2010.

The Veteran's appeal for a higher rating for PTSD was withdrawn. Service connection for prostate cancer and ischemic heart disease, both presumed to be due to herbicide exposure during service, is granted.

The Veteran's prostate cancer residuals are rated at 40 percent effective March 1, 2011 due to daytime voiding interval of less than one hour and awakening to void five or more times per night.

The Board has granted an effective date of April 11, 2010 for a 70 percent rating for major depressive disorder. The claim for service connection for prostate cancer is denied.

The Board has ordered a remand due to the need for additional medical examination and consideration of the Veteran's claims.

The Board has determined that a VA examination is needed to determine if the Veteran's prostate cancer is related to his service, specifically his exposure to herbicides other than Agent Orange and ionizing radiation at Moffett Field. The case will be remanded for this purpose.

The Veteran's claims for increased evaluation of prostate cancer and TDIU are being remanded due to the need for additional development, including obtaining recent VA treatment records and scheduling new examinations.

The Veteran's prostate cancer was not incurred in or aggravated by his military service. The Board found no evidence of radiation exposure during service and thus could not establish service connection based on the presumptive provisions for ionizing radiation.

The Veteran's appeal is denied as his residuals of prostate cancer are currently rated at 40 percent, which is the maximum schedular rating available.

The Board has granted service connection for prostate cancer as secondary to the service-connected enlarged prostate.

The Veteran's prostate cancer residuals are rated at 40 percent, and he is seeking a higher rating. His TDIU claim has also been raised.

The Veteran's prostate cancer was reopened and granted service connection, with a rating of 70 percent effective December 1, 2007. The discontinuance of SMC based on loss of use of one eye is restored.

The Veteran's PTSD was granted a 70 percent rating effective July 1, 2014. His diabetes mellitus and prostate cancer were both rated at their maximum schedular ratings.

The Veteran's appeal is being remanded for additional development, including obtaining medical records and an examination to clarify the nature of his service-connected disabilities and their impact on his claimed conditions.

The Veteran's residuals of prostate cancer, including voiding dysfunction, have been rated at 20 percent prior to June 4, 2013, and increased to 40 percent thereafter. The disability is currently evaluated as a result of the service-connected condition.